FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 48 filers reported holding FORTRESS BIOTECH INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,586 | -47.2% | 12,350 | 0.0% | 0.00% | – |
| Q2 2023 | $6,793 | -32.9% | 12,350 | 0.0% | 0.00% | – |
| Q1 2023 | $10,127 | +22.1% | 12,350 | 0.0% | 0.00% | – |
| Q4 2022 | $8,295 | -65.4% | 12,350 | -56.2% | 0.00% | – |
| Q3 2022 | $24,000 | +33.3% | 28,201 | +28.4% | 0.00% | – |
| Q2 2022 | $18,000 | -33.3% | 21,959 | +9.7% | 0.00% | – |
| Q1 2022 | $27,000 | +12.5% | 20,020 | +113.0% | 0.00% | – |
| Q4 2021 | $24,000 | +166.7% | 9,400 | +235.7% | 0.00% | – |
| Q3 2021 | $9,000 | -30.8% | 2,800 | -26.3% | 0.00% | – |
| Q2 2021 | $13,000 | -48.0% | 3,800 | -45.7% | 0.00% | – |
| Q1 2021 | $25,000 | +13.6% | 7,000 | 0.0% | 0.00% | – |
| Q4 2020 | $22,000 | -77.1% | 7,000 | -70.7% | 0.00% | – |
| Q3 2020 | $96,000 | +209.7% | 23,878 | +101.0% | 0.00% | – |
| Q2 2020 | $31,000 | +416.7% | 11,878 | +293.8% | 0.00% | – |
| Q1 2020 | $6,000 | – | 3,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,000,000 | $580,600 | 0.19% |
| Nantahala Capital Management | 6,018,211 | $1,747,087 | 0.15% |
| THOMPSON DAVIS & CO., INC. | 12,996 | $3,773 | 0.01% |
| Platform Technology Partners | 30,000 | $8,709 | 0.00% |
| Black Maple Capital Management LP | 15,000 | $4,355 | 0.00% |
| Arete Wealth Advisors, LLC | 52,547 | $15,254 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 144,700 | $42,006 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 1,075,531 | $311 | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 1,542,000 | $447,643 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,000 | $581 | 0.00% |